on tardive dyskinesia (TD), so you can help your patients focus on what matters most

Not an actual patient
The only VMAT2 inhibitor that offers the ease of one capsule, once daily1
VMAT2=vesicular monoamine transporter 2.

Get exclusive expert content

Become an INGREZZA Insider to get tardive dyskinesia (TD) screening videos, interactive challenges, educational tools, and more.

Register now

Already an INGREZZA Insider? Log in

Tardive dyskinesia can affect different areas of the body and may be disruptive2-5

Not an actual patient
See the impact

Tardive dyskinesia requires unique assessment and management


INGREZZA provided reductions in tardive dyskinesia severity1

Not an actual patient
View efficacy

Watch tardive dyskinesia screening videos

Person with bipolar disorder exhibiting select TD symptoms

Person with schizophrenia exhibiting select TD symptoms

Not actual patients
Log in to INGREZZA Insider